Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine

Seminars in Cell and Developmental Biology

Volumn 20, Issue 6, 2009, Pages 646-655

  Sundelacruz, Sarah ^a   Kaplan, David L ^a  

^a Tufts University   (United States)

Author keywords

Bone development; Bone healing; Osteochondral; Regenerative medicine; Tissue engineering

Indexed keywords

BIOMATERIAL; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGEN TYPE 9; FIBRONECTIN; HYALURONIC ACID; PROCOLLAGEN C PROTEINASE; SOMATOMEDIN C; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA;

BIOENGINEERING; BONE DEVELOPMENT; BONE DISEASE; BONE INJURY; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; DEVELOPMENTAL BIOLOGY; EMBRYO DEVELOPMENT; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; FRACTURE; FRACTURE HEALING; GEOMETRY; HUMAN; IN VITRO STUDY; LIMB; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; POROSITY; REGENERATIVE MEDICINE; REVIEW; SKIN FIBROBLAST; STEM CELL; STEM CELL TRANSPLANTATION; STIMULUS RESPONSE; TISSUE ENGINEERING;

EID: 67649433434     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2009.03.017     Document Type: Review

References (112)

1. Shum L., Coleman C.M., Hatakeyama Y., and Tuan R.S. Morphogenesis and dysmorphogenesis of the appendicular skeleton. Birth Defects Res Embryo Today: Rev 69 (2003) 102-122
2. Mackie E.J., Ahmed Y.A., Tatarczuch L., Chen K.S., and Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40 (2008) 46-62
3. Dawson J.I., and Oreffo R.O.C. Bridging the regeneration gap: stem cells, biomaterials and clinical translation in bone tissue engineering. Arch Biochem Biophys 473 (2008) 124-131
4. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., and Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88 (2003) 873-884
5. Baksh D., Song L., and Tuan R.S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8 (2004) 301-316
6. Breitbart A.S., Grande D.A., Kessler R., Ryaby J.T., Fitzsimmons R.J., and Grant R.T. Tissue engineered bone repair of calvarial defects using cultured periosteal cells. Plast Reconstr Surg 101 (1998) 567-576
7. Brighton C.T., and Hunt R.M. Early histological and ultrastructural changes in medullary fracture callus. J Bone Joint Surg Ser A 73 (1991) 832-847
8. Caplan A.I. Bone development and repair. BioEssays 6 (1987) 171-175
9. Colnot C., Huang S., and Helms J. Analyzing the cellular contribution of bone marrow to fracture healing using bone marrow transplantation in mice. Biochem Biophys Res Commun 350 (2006) 557-561
10. Eghbali-Fatourechi G.Z., Lamsam J., Fraser D., Nagel D., Riggs B.L., and Khosla S. Circulating osteoblast-lineage cells in humans. New Engl J Med 352 (2005) 1959-1966
11. Malizos K.N., and Papatheodorou L.K. The healing potential of the periosteum molecular aspects. Injury 36 Suppl. 3 (2005) S13-19
12. Rumi M.N., Deol G.S., Singapuri K.P., and Pellegrini Jr. V.D. The origin of osteoprogenitor cells responsible for heterotopic ossification following hip surgery: an animal model in the rabbit. J Orthop Res 23 (2005) 34-40
13. Yoo J.U., Barthel T.S., Nishimura K., Solchaga L., Caplan A.I., Goldberg V.M., et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Ser A 80 (1998) 1745-1757
14. Yoo J.U., and Johnstone B. The role of osteochondral progenitor cells in fracture repair. Clinic Orthop (1998) S73-81
15. Lieberman J.R., Daluiski A., and Einhorn T.A. The role of growth factors in the repair of bone biology and clinical applications. J Bone Joint Surg Ser A 84 (2002) 1032-1044
16. Reddi A.H. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Ser A 83 A Suppl. 1 (2001) S1-6
17. Sakou T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22 (1998) 591-603
18. Bostrom M.P.G., Lane J.M., Berberian W.S., Missri A.A.E., Tomin E., Weiland A., et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13 (1995) 357-367
19. Dimitriou R., Tsiridis E., and Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 36 (2005) 1392-1404
20. Ferguson C., Alpern E., Miclau T., and Helms J.A. Does adult fracture repair recapitulate embryonic skeletal formation?. Mech Dev 87 (1999) 57-66
21. Probst A., and Spiegel H.U. Cellular mechanisms of bone repair. J Invest Surg 10 (1997) 77-86
22. Einhorn T.A., Majeska R.J., Rush E.B., Levine P.M., and Horowitz M.C. The expression of cytokine activity by fracture callus. J Bone Mineral Res 10 (1995) 1272-1281
23. Kon T., Cho T.J., Aizawa T., Yamazaki M., Nooh N., Graves D., et al. Expression of osteoprotegerin, receptor activator of NF-κB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Mineral Res 16 (2001) 1004-1014
24. Stocum D.L., and Zupanc G.K.H. Stretching the limits: stem cells in regeneration science. Dev Dyn 237 (2008) 3648-3671
25. Tögel F., and Westenfelder C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn 236 (2007) 3321-3331
26. Tuan R.S. Biology of developmental and regenerative skeletogenesis. Clinic Orthop (2004) S105-S117
27. Schnabel M., Marlovits S., Eckhoff G., Fichtel I., Gotzen L., VeÌcsei V., et al. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 10 (2002) 62-70
28. Friedenstein A.J., Chailakhjan R.K., and Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics 3 (1970) 393-403
29. Friedenstein A.J., Chailakhyan R.K., and Latsinik N.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues, cloning in vitro and retransplantation in vivo. Transplantation 17 (1974) 331-340
30. Friedenstein A.J., Deriglasova U.F., and Kulagina N.N. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2 (1974) 83-92
31. Arthur A., Zannettino A., and Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 218 (2009) 237-245
32. Chamberlain G., Fox J., Ashton B., and Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25 (2007) 2739-2749
33. Gojo S., Gojo N., Takeda Y., Mori T., Abe H., Kyo S., et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 288 (2003) 51-59
34. Hofstetter C.P., Schwarz E.J., Hess D., Widenfalk J., El Manira A., Prockop D.J., et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 99 (2002) 2199-2204
35. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107 (2001) 1395-1402
36. Kopen G.C., Prockop D.J., and Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96 (1999) 10711-10716
37. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98 (2001) 10344-10349
38. Barbash I.M., Chouraqui P., Baron J., Feinberg M.S., Etzion S., Tessone A., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108 (2003) 863-868
39. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1011
40. Mahmood A., Lu D., Lu M., Chopp M., Amar A.P., Brawanski A., et al. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53 (2003) 697-703
41. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100 (2003) 8407-8411
42. Fox J.M., Chamberlain G., Ashton B.A., and Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137 (2007) 491-502
43. Dessau W., Von Der Mark H., Von der Mark K., and Fischer D. Changes in the patterns of collagens and fibronectin during limb-bud chondrogenesis. J Embryol Exp Morphol 57 (1980) 51-60
44. Kulyk W.M., Upholt W.B., and Kosher R.A. Fibronectin gene expression during limb cartilage differentiation. Development 106 (1989) 449-455
45. Oberlender S.A., and Tuan R.S. Spatiotemporal profile of N-cadherin expression in the developing limb mesenchyme. Cell Adhes Commun 2 (1994) 521-537
46. Tavella S., Raffo P., Tacchetti C., Cancedda R., and Castagnola P. N-CAM and N-cadherin expression during in vitro chondrogenesis. Exp Cell Res 215 (1994) 354-362
47. Knudson C.B., and Hyaluronan. CD44: strategic players for cell-matrix interactions during chondrogenesis and matrix assembly. Birth Defects Res Embryo Today: Rev 69 (2003) 174-196
48. Knudson C.B., and Toole B.P. Hyaluronate-cell interactions during differentiation of chick embryo limb mesoderm. Dev Biol 124 (1987) 82-90
49. Toole B.P., Jackson G., and Gross J. Hyaluronate in morphogenesis: inhibition of chondrogenesis in vitro. Proc Natl Acad Sci U S A 69 (1972) 1384-1386
50. Toole B.P., and Linsenmayer T.F. Newer knowledge of skeletogenesis: macromolecular transitions in the extracellular matrix. Clin Orthop 129 (1977) 258-278
51. Schindeler A., McDonald M.M., Bokko P., and Little D.G. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 19 (2008) 459-466
52. Van Der Eerden B.C.J., Karperien M., and Wit J.M. Systemic and local regulation of the growth plate. Endocr Rev 24 (2003) 782-801
53. Tchetina E.V., Kobayashi M., Yasuda T., Meijers T., Pidoux I., and Poole A.R. Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis. Matrix Biol 26 (2007) 247-258
54. Ortega N., Behonick D.J., and Werb Z. Matrix remodeling during endochondral ossification. Trends Cell Biol 14 (2004) 86-93
55. McKibbin B. The biology of fracture healing in long bones. Journal of Bone and Joint Surgery-Series B 60 B (1978) 150-162
56. Karageorgiou V., Meinel L., Hofmann S., Malhotra A., Volloch V., and Kaplan D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 71 (2004) 528-537
57. Sofia S., McCarthy M.B., Gronowicz G., and Kaplan D.L. Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res 54 (2001) 139-148
58. Wang X., Kim H.J., Xu P., Matsumoto A., and Kaplan D.L. Biomaterial coatings by stepwise deposition of silk fibroin. Langmuir 21 (2005) 11335-11341
59. Wang X., Hu X., Daley A., Rabotyagova O., Cebe P., and Kaplan D.L. Nanolayer biomaterial coatings of silk fibroin for controlled release. J Control Release 121 (2007) 190-199
60. Kim U.J., Park J., Li C., Jin H.J., Valluzzi R., and Kaplan D.L. Structure and properties of silk hydrogels. Biomacromolecules 5 (2004) 786-792
61. Wang Y., Kim H.J., Vunjak-Novakovic G., and Kaplan D.L. Stem cell-based tissue engineering with silk biomaterials. Biomaterials 27 (2006) 6064-6082
62. Aoki H., Tomita N., Morita Y., Hattori K., Harada Y., Sonobe M., et al. Culture of chondrocytes in fibroin-hydrogel sponge. Biomed Mater Eng 13 (2003) 309-316
63. Morita Y., Tomita N., Aoki H., Sonobe M., Wakitani S., Tamada Y., et al. Frictional properties of regenerated cartilage in vitro. J Biomech 39 (2006) 103-109
64. Morita Y., Tomita N., Aoki H., Wakitani S., Tamada Y., Suguro T., et al. Visco-elastic properties of cartilage tissue regenerated with fibroin sponge. Biomed Mater Eng 12 (2002) 291-298
65. Fini M., Motta A., Torricelli P., Giavaresi G., Nicoli Aldini N., Tschon M., et al. The healing of confined critical size cancellous defects in the presence of silk fibroin hydrogel. Biomaterials 26 (2005) 3527-3536
66. Kim H.J., Kim H.S., Matsumoto A., Chin I.J., Jin H.J., and Kaplan D.L. Processing windows for forming silk fibroin biomaterials into a 3D porous matrix. Aust J Chem 58 (2005) 716-720
67. Kim U.J., Park J., Joo Kim H., Wada M., and Kaplan D.L. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 26 (2005) 2775-2785
68. Nazarov R., Jin H.J., and Kaplan D.L. Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules 5 (2004) 718-726
69. Wang Y., Blasioli D.J., Kim H.J., Kim H.S., and Kaplan D.L. Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials 27 (2006) 4434-4442
70. Wang Y., Kim U.J., Blasioli D.J., Kim H.J., and Kaplan D.L. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials 26 (2005) 7082-7094
71. Hofmann S., Knecht S., Langer R., Kaplan D.L., Vunjak-Novakovic G., Merkle H.P., et al. Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng 12 (2006) 2729-2738
72. Meinel L., Hofmann S., Karageorgiou V., Zichner L., Langer R., Kaplan D., et al. Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol Bioeng 88 (2004) 379-391
73. Meinel L., Fajardo R., Hofmann S., Langer R., Chen J., Snyder B., et al. Silk implants for the healing of critical size bone defects. Bone 37 (2005) 688-698
74. Meinel L., Karageorgiou V., Fajardo R., Snyder B., Shinde-Patil V., Zichner L., et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 32 (2004) 112-122
75. Meinel L., Karageorgiou V., Hofmann S., Fajardo R., Snyder B., Li C., et al. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A 71 (2004) 25-34
76. Ahu Akin F., Zreiqat H., Jordan S., Wijesundara M.B.J., and Hanley L. Preparation and analysis of macroporous TiO2 films on Ti surfaces for bone-tissue implants. J Biomed Mater Res 57 (2001) 588-596
77. Karageorgiou V., and Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26 (2005) 5474-5491
78. Takahashi Y., and Tabata Y. Effect of the fiber diameter and porosity of non-woven PET fabrics on the osteogenic differentiation of mesenchymal stem cells, Journal of Biomaterials Science. Polymer Ed 15 (2004) 41-57
79. Dutta Roy T., Simon J.L., Ricci J.L., Rekow E.D., Thompson V.P., and Parsons J.R. Performance of degradable composite bone repair products made via three-dimensional fabrication techniques. J Biomed Mater Res A 66 (2003) 283-291
80. Jin Q.M., Takita H., Kohgo T., Atsumi K., Itoh H., and Kuboki Y. Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation. J Biomed Mater Res 52 (2000) 491-499
81. Kuboki Y., Jin Q., Kikuchi M., Mamood J., and Takita H. Geometry of artificial ECM: sizes of pores controlling phenotype expression in BMP-induced osteogenesis and chondrogenesis. Connect Tissue Res 43 (2002) 529-534
82. Kuboki Y., Jin Q., and Takita H. Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J Bone Joint Surg Ser A 83 (2001) S1105-1115
83. Uebersax L., HagenmuÌller H., Hofmann S., Gruenblatt E., MuÌller R., Vunjak-Novakovic G., et al. Effect of scaffold design on bone morphology in vitro. Tissue Eng 12 (2006) 3417-3429
84. Hofmann S., HagenmuÌller H., Koch A.M., MuÌller R., Vunjak-Novakovic G., Kaplan D.L., et al. Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials 28 (2007) 1152-1162
85. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 24 (2003) 401-416
86. Vepari C., and Kaplan D.L. Silk as a biomaterial. Prog Polymer Sci (Oxford) 32 (2007) 991-1007
87. Dawson E., Mapili G., Erickson K., Taqvi S., and Roy K. Biomaterials for stem cell differentiation. Adv Drug Deliv Rev 60 (2008) 215-228
88. Horan R.L., Antle K., Collette A.L., Wang Y., Huang J., Moreau J.E., et al. In vitro degradation of silk fibroin. Biomaterials 26 (2005) 3385-3393
89. Wang Y., Rudym D.D., Walsh A., Abrahamsen L., Kim H.J., Kim H.S., et al. In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials 29 (2008) 3415-3428
90. Gerstenfeld L.C., Barnes G.L., Shea C.M., and Einhorn T.A. Osteogenic differentiation is selectively promoted by morphogenetic signals from chondrocytes and synergized by a nutrient rich growth environment. Connect Tissue Res 44 (2003) 85-91
91. Le A.X., Miclau T., Hu D., and Helms J.A. Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res 19 (2001) 78-84
92. Barnes G.L., Kostenuik P.J., Gerstenfeld L.C., and Einhorn T.A. Growth factor regulation of fracture repair. J Bone Mineral Res 14 (1999) 1805-1815
93. Goldring M.B., Tsuchimochi K., and Ijiri K. The control of chondrogenesis. J Cell Biochem 97 (2006) 33-44
94. Yokouchi Y., Sakiyama J.I., Kameda T., Iba H., Suzuki A., Ueno N., et al. BMP-2/-4 mediate programmed cell death in chicken limb buds. Development 122 (1996) 3725-3734
95. Carey D.E., and Liu X. Expression of bone morphogenetic protein-6 messenger RNA in bovine growth plate chondrocytes of different size. J Bone Mineral Res 10 (1995) 401-405
96. Franzen P., Ten Dijke P., Ichijo H., Yamashita H., Schulz P., Heldin C.H., et al. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75 (1993) 681-692
97. Cho T.J., Gerstenfeld L.C., and Einhorn T.A. Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing. J Bone Mineral Res 17 (2002) 513-520
98. Nakase T., Nomura S., Yoshikawa H., Hashimoto J., Hirota S., Kitamura Y., et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Mineral Res 9 (1994) 651-659
99. Betz V.M., Betz O.B., Harris M.B., Vrahas M.S., and Evans C.H. Bone tissue engineering and repair by gene therapy. Front Biosci 13 (2008) 833-841
100. Karageorgiou V., Tomkins M., Fajardo R., Meinel L., Snyder B., Wade K., et al. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A 78 (2006) 324-334
101. Li C., Vepari C., Jin H.J., Kim H.J., and Kaplan D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27 (2006) 3115-3124
102. Chen J., Altman G.H., Karageorgiou V., Horan R., Collette A., Volloch V., et al. Human bone marrow stromal cell and ligament fibroblast responses on RGD-modified silk fibers. J Biomed Mater Res A 67 (2003) 559-570
103. Gersbach C.A., Phillips J.E., and GarciÌa A.J. Genetic engineering for skeletal regenerative medicine. Ann Rev Biomed Eng (2007) 87-119
104. Jones A.C., Arns C.H., Hutmacher D.W., Milthorpe B.K., Sheppard A.P., and Knackstedt M.A. The correlation of pore morphology, interconnectivity and physical properties of 3D ceramic scaffolds with bone ingrowth. Biomaterials 30 (2009) 1440-1451
105. Liu X., and Ma P.X. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 32 (2004) 477-486
106. Murphy W.L., Dennis R.G., Kileny J.L., and Mooney D.J. Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng 8 (2002) 43-52
107. Nair L.S., and Laurencin C.T. Biodegradable polymers as biomaterials. Prog Polymer Sci(Oxford) 32 (2007) 762-798
108. Burg K.J.L., Porter S., and Kellam J.F. Biomaterial developments for bone tissue engineering. Biomaterials 21 (2000) 2347-2359
109. Hutmacher D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 21 (2000) 2529-2543
110. Raghunath J., Rollo J., Sales K.M., Butler P.E., and Seifalian A.M. Biomaterials and scaffold design: key to tissue-engineering cartilage. Biotechnol Appl Bioch 46 (2007) 73-84
111. Rezwan K., Chen Q.Z., Blaker J.J., and Boccaccini A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27 (2006) 3413-3431
112. Cartmell S. Controlled release scaffolds for bone tissue engineering. J Pharm Sci 98 (2009) 430-441